Advertisement
Screener

VIEMED HEALTHCARE, INC. (VMD) Debt / Equity

VIEMED HEALTHCARE, INC. Debt/Equity Ratio

The debt/equity ratio shows how much a company has borrowed for every dollar its shareholders have put in. It is long-term debt, both the part due within a year and the rest, divided by shareholder equity, shown as a multiple with both amounts in the table. A higher ratio means the company relies more on borrowed money than on shareholder capital. Because equity shrinks through buybacks or losses, the ratio can rise even when debt is unchanged, and it has no meaning when equity is negative. Quarterly points use quarter-end balances; annual points use fiscal-year-end balances.

  • VIEMED HEALTHCARE, INC. debt/equity ratio for the quarter ending 2026-06-30 was 0.05, a 60.55% increase year-over-year.
  • VIEMED HEALTHCARE, INC. debt/equity ratio for the quarter ending 2026-03-31 was 0.06, a 119.96% increase year-over-year.
  • VIEMED HEALTHCARE, INC. debt/equity ratio for the quarter ending 2025-12-31 was 0.09, a 187.47% increase year-over-year.
  • VIEMED HEALTHCARE, INC. debt/equity ratio for the quarter ending 2025-09-30 was 0.16, a 343.09% increase year-over-year.
  • VIEMED HEALTHCARE, INC. debt/equity ratio for fiscal 2025 was 0.09, a 187.47% increase from fiscal 2024.
  • VIEMED HEALTHCARE, INC. debt/equity ratio for fiscal 2024 was 0.03, a 51.01% decline from fiscal 2023.
  • VIEMED HEALTHCARE, INC. debt/equity ratio for fiscal 2023 was 0.06, a change of 0.06 from fiscal 2022.
  • VIEMED HEALTHCARE, INC. debt/equity ratio for fiscal 2022 was 0, a 100.00% decline from fiscal 2021.
Available history
2018-03-31 to 2026-06-30
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity RatioLong-term debtShareholder equity
2026-06-300.05$7.09M$144.03M
2026-03-310.06$9.21M$143.86M
2025-12-310.09$12.38M$141.55M
2025-09-300.16$21.14M$133.61M
2025-06-300.03$4.29M$139.73M
2025-03-310.03$3.92M$134.76M
2024-12-310.03$4M$131.39M
2024-09-300.04$4.46M$124.96M
2024-06-300.08$9.49M$119.37M
2024-03-310.06$6.5M$116.27M
2023-12-310.06$7.07M$113.9M
2023-09-300.09$9.93M$108.81M
2023-06-300.15$15.28M$104.51M
2022-12-310$0.00$97.09M
2022-09-300.05$4.32M$93.91M
2022-06-300.05$4.84M$93.23M
2022-03-310.06$5.32M$96.04M
2021-12-310.06$5.79M$94.82M
2021-09-300.07$6.25M$89.38M
2021-06-300.08$6.73M$86.26M
2021-03-310.09$7.18M$83.42M
2020-12-310.09$7.63M$81.69M
2020-09-300.11$8.08M$75.2M
2020-06-300.12$8.52M$71.13M
2020-03-310.18$8.95M$48.8M
2019-12-310.21$9.38M$43.7M
2019-09-300.24$9.8M$40.33M
2019-06-300.13$4.84M$36.14M
2019-03-310$0.00$33.89M
2018-12-310$0.00$32.57M
2018-09-300$0.00$30.39M
2018-06-300$0.00$27.5M
2018-03-310$0.00$24.74M

Annual Debt/Equity Ratio

DateDebt/Equity RatioLong-term debtShareholder equity
2025-12-310.09$12.38M$141.55M
2024-12-310.03$4M$131.39M
2023-12-310.06$7.07M$113.9M
2022-12-310$0.00$97.09M
2021-12-310.06$5.79M$94.82M
2020-12-310.09$7.63M$81.69M
2019-12-310.21$9.38M$43.7M
2019-09-300.24$9.8M$40.32M
2019-06-300.13$4.84M$36.14M
2019-03-310$0.00$33.89M
2018-12-310$0.00$32.57M
2018-09-300$0.00$30.39M
2018-06-300$0.00$27.5M
2018-03-310$0.00$24.74M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Park Dental Partners, Inc. (PARK)United States$0.094B
BioRestorative Therapies, Inc. (BRTX)United States$0.064B
CRYO CELL INTERNATIONAL INC (CCEL)United States$0.033B-11.02
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43
agilon health, inc. (AGL)United States$1.272B-7.76
Progyny, Inc. (PGNY)United States$1.994B28.37
Sotera Health Co (SHC)United States$5.271B30.96
DAVITA INC. (DVA)United States$11.147B16.80